ENNews
Medical news from Germany: research, hospitals, treatment methods — from the press offices of university hospitals and institutes.
European CE Mark Approval Granted for da Vinci 5 in Cardiac Surgery
The da Vinci 5 system has received CE marking in Europe for adult cardiac interventions, expanding minimally invasive coronary bypass and thoracoscopic procedures in Germany.
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
ACS Pathfinder approved as a medical device to support heart attack diagnosis
Developed at UKE with support from DZHK, the ACS Pathfinder algorithm has received CE certification and a European patent for rapid, precise heart attack rule-out.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
Consensus Guideline for Bacteriophage Therapy in Bone and Implant Infections
An international consensus guideline published in Nature Medicine establishes standards for personalized bacteriophage therapy in complex orthopedic infections.
Preventing Stomach Cancer Before It Starts: Breakthrough at Charité
Researchers at Charité have discovered how Helicobacter pylori reprograms stomach tissue, creating new possibilities for early molecular cancer prevention.
Inhaled mosliciguat shows clinical promise in pulmonary hypertension
Phase 2 PHocus trial results demonstrate significant hemodynamic and functional progress with inhaled mosliciguat in patients with PH-ILD.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
New Retinal Chip PRIMA Restores Central Vision in Geographic Atrophy
A newly approved photovoltaic subretinal chip offers restored visual function for patients with central vision loss from geographic atrophy due to dry AMD.
Clinical Trial Examines ATreg Cells to Prevent Transplant Complications
Researchers in Germany successfully tested donor regulatory T cells to prevent graft-versus-host disease following allogeneic stem cell transplantation.
Catheter ablation for atrial fibrillation after mitral valve repair
The CABA-MiTRA-AFNET12-DZHK34 clinical trial has been launched in Germany to evaluate catheter ablation in patients following transcatheter mitral valve repair.
Activated Regulatory T Cells Tested to Prevent Stem Cell Transplant Complication
German researchers report successful Phase I/II clinical trial results for a novel cell therapy designed to prevent acute graft-versus-host disease in stem cell patients.
